Sculptor Capital’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Sculptor Capital’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-212,500	Closed	-$2.08K	–	845
2022 Q4	$2.08K	Hold	212,500	–	–	﹤0.01%	769
2022 Q3	$21K	Hold	212,500	–	–	﹤0.01%	874
2022 Q2	$15K	Hold	212,500	–	–	﹤0.01%	1063
2022 Q1	$39K	Hold	212,500	–	–	﹤0.01%	1112
2021 Q4	$114K	Hold	212,500	–	–	﹤0.01%	962
2021 Q3	$122K	Hold	212,500	–	–	﹤0.01%	819
2021 Q2	$160K	Buy	+212,500	New	+$129K	﹤0.01%	791

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Sculptor Capital's IBER.WS Position: Q1 2023 in Review

Sculptor Capital sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 212,500 shares — an estimated $2.08K sold.

Sculptor Capital first reported a position in IBER.WS in Q2 2021 and held it in 7 quarters. The position peaked at $160K in Q2 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Sculptor Capital reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Sculptor Capital sold 212,500 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $2.08K.
Sculptor Capital first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2021 and held it in 7 quarters.
Sculptor Capital's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $160K in Q2 2021.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.